NCT07390721 Diaphragmatic Kinesio Taping With HIIT in Trained Individuals
| NCT ID | NCT07390721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Agri Ibrahim Cecen University |
| Condition | Postural Balance |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-09-01 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines whether adding diaphragmatic kinesio taping to high-intensity interval training (HIIT) improves physical performance in trained individuals. Participants will be randomly assigned to one of two groups. One group will perform an 8-week HIIT program on a cycle ergometer. The other group will follow the same HIIT program and will also receive diaphragmatic kinesio taping before each exercise session. The taping is applied to support breathing muscles and may help improve oxygen use during exercise. Before and after the training period, participants will undergo tests to measure aerobic capacity (VO₂max), anaerobic power (Wingate test), balance (Y-Balance test), lung function (spirometry), body composition, and heart rate responses. The results of this study will help determine whether diaphragmatic kinesio taping provides additional benefits when combined with HIIT training.
Eligibility Criteria
Inclusion Criteria: * Aged 18-35 years * Male or female trained individuals * At least 6 months of regular training history * Training at least 3-5 days per week * Estimated VO₂max ≥ 50 ml/kg/min * No known contraindication to high-intensity exercise * No allergy or skin condition preventing kinesio taping * Able to provide written informed consent Exclusion Criteria: * History of cardiovascular, respiratory, or metabolic disease (e.g., asthma, COPD, diabetes, heart disease) * Major musculoskeletal injury or surgery within the past 6 months * Any pathology affecting diaphragm or respiratory muscles * Active smoking or substance abuse * Use of performance-enhancing drugs * Skin disease in the abdominal region
Contact & Investigator
Fadıl Özyener, Prof. Dr.
STUDY DIRECTOR
Uludag University
Frequently Asked Questions
Who can join the NCT07390721 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Postural Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07390721 currently recruiting?
Yes, NCT07390721 is actively recruiting participants. Contact the research team at dayilmaz@agri.edu.tr for enrollment information.
Where is the NCT07390721 trial being conducted?
This trial is being conducted at Bursa, Turkey (Türkiye).
Who is sponsoring the NCT07390721 clinical trial?
NCT07390721 is sponsored by Agri Ibrahim Cecen University. The principal investigator is Fadıl Özyener, Prof. Dr. at Uludag University. The trial plans to enroll 30 participants.